Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Prostaglandins and lipid modification.

G Sobal¹, H Sinzinger

¹Department of Nuclear Medicine, University of Vienna, Vienna, Austria. Helmut.Sinzinger@akh-wien.ac.at

Current Pharmaceutical Design

|April 3, 2001

Summary

Prostaglandins and low-density lipoproteins are key in atherogenesis, influencing plaque formation. Further research is needed to fully understand their complex vascular interactions and roles in disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modification of low-density lipoprotein during radiolabeling with 99mTc using three labeling methods.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2006

Same author

Modification of low-density lipoprotein by different radioiodination methods.

Nuclear medicine and biology·2004

Same author

Troglitazone-binding to LDL and its glycated modifications: its role in cell-catalysed and Cu-mediated LDL-oxidation.

Life sciences·2003

Same author

Binding of [99mTc]chondroitin sulfate to scavenger receptors on human chondrocytes as compared to binding of oxidized [125I]LDL on human macrophages.

Journal of receptor and signal transduction research·2002

Same author

Methylene blue-enhanced stability of (99mTc)HMPAO and simplified quality control--a comparative investigation.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2001

Same author

Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.

Biochemical pharmacology·2001

Area of Science:

Cardiovascular Biology
Lipid Metabolism
Inflammation & Immunology

Background:

Prostaglandins (PG) and low-density lipoproteins (LDL) are integral to atherogenesis.
Their interaction within the vascular system is crucial for plaque development and progression.
The precise mechanisms of these interactions require further elucidation.

Purpose of the Study:

To investigate the intricate relationship between prostaglandins and low-density lipoproteins in the context of atherogenesis.
To explore how lipoproteins influence PG production and how PGs affect lipoprotein metabolism.
To understand the role of modified LDL and isoprostanes in proatherogenic processes.

Main Methods:

Analysis of lipoprotein influence on prostaglandin production by arterial cells and platelets.
Assessment of prostaglandin effects on lipoprotein receptor binding and arterial wall entry.
Investigation of LDL modification, including the formation and effects of isoprostanes like 8-epi PGF(2alpha).

Main Results:

Lipoproteins modulate prostaglandin synthesis in vascular cells and platelets.
Prostaglandins influence lipoprotein uptake into the arterial wall.
LDL modification leads to the formation of proatherogenic isoprostanes, such as 8-epi PGF(2alpha), which promote vasoconstriction and platelet activation.

Conclusions:

The interplay between prostaglandins and lipoproteins is a significant factor in atherogenesis.
Modified LDL and associated isoprostanes contribute to plaque progression through various proatherogenic mechanisms.
Further research is warranted to assess the impact of eicosanoids on lipoprotein modification.

Related Experiment Videos